Carregant...

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study

OBJECTIVE: Gabapentin and its prodrug are candidate therapeutic agents for akathisia. An open-label pilot study was conducted to investigate the therapeutic potential of gabapentin enacarbil (GE) for akathisia. METHODS: In an open-labeled investigator-initiated clinical trial, nine outpatients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuropsychiatr Dis Treat
Autors principals: Takeshima, Masahiro, Ishikawa, Hiroyasu, Kanbayashi, Takashi, Shimizu, Tetsuo
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6257366/
https://ncbi.nlm.nih.gov/pubmed/30538475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S184081
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!